Related Experiment Video
Updated: May 30, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
271
Recent advances in immunotherapy for cervical cancer
Aiko Ogasawara1, Kosei Hasegawa2
1Department of Gynecologic Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan.
International Journal of Clinical Oncology
|January 31, 2025
Summary
Cervical cancer treatments are advancing with immune checkpoint inhibitors (ICI) and combination therapies. Research explores novel immunotherapies like CAR-T cell therapy to improve outcomes for advanced cervical cancer patients.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Cervical cancer is a major global health concern for women.
- Current treatment strategies are evolving rapidly, especially for advanced stages.
Purpose of the Study:
- To review current immunotherapy strategies for cervical cancer.
- To describe novel treatment options and ongoing clinical trials.
Main Methods:
- Literature review of articles on cervical cancer immunotherapy.
- Analysis of clinical trials involving immune checkpoint inhibitors (ICI).
Main Results:
- Cemiplimab, an ICI, showed improved prognosis in advanced/metastatic cervical cancer.
- Combination therapies (ICI with chemo/radiation/other immune therapies) are under investigation.
- Emerging immunotherapies include therapeutic vaccination and cell therapies (CAR-T, TILs).
Conclusions:
- Immunotherapy, particularly ICI, offers promising new avenues for cervical cancer treatment.
- Combination strategies and novel approaches are crucial for overcoming treatment challenges and improving patient outcomes.
Related Concept Videos
01:30Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
833
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
833